Recent studies indicate that lncRNA-FGF14-AS2 serves as a tumor inhibitor by sponging miR-370-3p, which has an inhibitory effect on FGF14, thereby restraining the migration and invasion of breast cancer cells (57). The gene discussed is FGF14; the disease is neoplasm.